These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30056191)

  • 1. Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability.
    Dworacka M; Iskakova S; Wesołowska A; Zharmakhanova G; Stelmaszyk A; Frycz BA; Jagodziński PP; Dworacki G
    Diabetes Res Clin Pract; 2018 Sep; 143():245-253. PubMed ID: 30056191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New arguments for beneficial effects of alpha-lipoic acid on the cardiovascular system in the course of type 2 diabetes.
    Dworacka M; Chukanova G; Iskakova S; Kurmambayev Y; Wesołowska A; Frycz BA; Jagodziński PP; Dworacki G
    Eur J Pharm Sci; 2018 May; 117():41-47. PubMed ID: 29427700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.
    Zhang W; Yan H
    Exp Eye Res; 2012 Dec; 105():1-8. PubMed ID: 23059402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
    Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
    Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin suppresses expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes.
    Lee SG; Kim JL; Lee HK; Ryu GW; Hur DY; Yun IH; Yang JW; Kim HW
    Graefes Arch Clin Exp Ophthalmol; 2011 Mar; 249(3):389-97. PubMed ID: 20821229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin increases circulating endothelial progenitor cells and inhibits the formation of intracranial aneurysms in rats with diet-induced hyperhomocysteinemia.
    Xu Y; Zhang B; Chen Y; Wang X; Li Y; Wu J; Dong H; Wang S
    Neurosci Lett; 2021 Aug; 760():136072. PubMed ID: 34147541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients.
    Szendroedi J; Anderwald C; Krssak M; Bayerle-Eder M; Esterbauer H; Pfeiler G; Brehm A; Nowotny P; Hofer A; Waldhäusl W; Roden M
    Diabetes Care; 2009 Feb; 32(2):209-14. PubMed ID: 18957532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simvastatin's effect on insulin resistance in rats with diabetes mellitus].
    Iskakova S; Zharmakhanova G; Bekmukhambetov Y; Dworacka M; Dworacki G
    Georgian Med News; 2015 May; (242):70-7. PubMed ID: 26042451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat.
    Thirunavukkarasu M; Selvaraju V; Dunna NR; Foye JL; Joshi M; Otani H; Maulik N
    Int J Cardiol; 2013 Oct; 168(3):2474-80. PubMed ID: 23590933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringin ameliorates atherogenic dyslipidemia but not hyperglycemia in rats with type 1 diabetes.
    Xulu S; Oroma Owira PM
    J Cardiovasc Pharmacol; 2012 Feb; 59(2):133-41. PubMed ID: 21964158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart].
    Di Napoli P; Maggi A; Spina R; Barsotti L; Taccardi AA; Stuppia L; Vianale G; Palka G; Barsotti A
    Cardiologia; 1999 Jan; 44(1):69-74. PubMed ID: 10188333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice.
    Huang PH; Chen JY; Chen CY; Chen JW; Lin SJ; Shih CC
    J Vasc Surg; 2016 Oct; 64(4):1112-1120.e1. PubMed ID: 26830691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus downregulates expression of connexin43 in rat aortic medial smooth muscle cells and can be reversed by simvastatin and losartan therapy.
    Sheu JJ; Tsai TH; Chang LT; Chiang CH; Youssef AA; Sun CK; Chang NK; Yip HK
    Chang Gung Med J; 2008; 31(2):136-44. PubMed ID: 18567413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.
    Bellia A; Rizza S; Galli A; Fabiano R; Donadel G; Lombardo MF; Cardillo C; Sbraccia P; Tesauro M; Lauro D
    Atherosclerosis; 2010 May; 210(1):199-201. PubMed ID: 20018286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.
    Takayama N; Kai H; Kudo H; Yasuoka S; Mori T; Anegawa T; Koga M; Kajimoto H; Hirooka Y; Imaizumi T
    Hypertens Res; 2011 Mar; 34(3):341-7. PubMed ID: 21124329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of streptozotocin-diabetic rat lung.
    Ozansoy G; Güven C; Ceylan A; Can B; Aktan F; Oz E; Gönül B
    Cell Biochem Funct; 2005; 23(6):421-6. PubMed ID: 15540254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin Alleviates Pathology in a Rat Model of Preeclampsia Involving ERK/MAPK Pathway.
    Dong X; Shi D
    Reprod Sci; 2017 Jul; 24(7):1053-1061. PubMed ID: 27856999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin promotes alveolar epithelial cell proliferation and attenuates cigarette smoke‑induced emphysema in rats.
    Xia S; Kang J; Jiang Y; Huang D; Wang S; Pang B
    Mol Med Rep; 2015 Oct; 12(4):5903-10. PubMed ID: 26239701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simvastatin on the expression of farnesoid X receptor in diabetic animal models of altered glucose homeostasis.
    Wang L; Huang X; Hu S; Ma X; Wang S; Pang S
    Chin Med J (Engl); 2014; 127(2):218-24. PubMed ID: 24438607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.
    Ceylan A; Karasu C; Aktan F; Ozansoy G
    Diabetes Nutr Metab; 2004 Aug; 17(4):203-10. PubMed ID: 15575340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.